A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma

The status of lymph nodes in the central compartment is crucial to determining the surgical strategies for papillary thyroid carcinoma (PTC). We aimed to develop a nomogram for predicting central lymph node metastasis (CLNM). A total of 886 PTC patients who underwent total thyroidectomy or lobectomy...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 12; p. 666315
Main Authors Feng, Jia-Wei, Hong, Li-Zhao, Wang, Fei, Wu, Wan-Xiao, Hu, Jun, Liu, Sheng-Yong, Jiang, Yong, Ye, Jing
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 28.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The status of lymph nodes in the central compartment is crucial to determining the surgical strategies for papillary thyroid carcinoma (PTC). We aimed to develop a nomogram for predicting central lymph node metastasis (CLNM). A total of 886 PTC patients who underwent total thyroidectomy or lobectomy with central neck dissection (CND) from July 2019 to June 2020 were retrospectively retrieved. Clinical and ultrasound features were collected. Univariate and multivariate analysis were performed to determine risk factors of CLNM. A nomogram for predicting CLNM was developed, internal and external calibration was performed for the established model. Variables (sex, chronic lymphocytic thyroiditis, tumor size, the number of foci, tumor location, margin) significantly associated with CLNM were included in the nomogram. The nomogram showed excellent calibration in the training group and validation group, with area under curves of 0.806 (95% CI, 0.771 to 0.825), and 0.799 (95% CI, 0.778-0.813) respectively. Through this accurate and easy-to-use nomogram, the possibility of CLNM can be objectively quantified preoperatively. Clinicians can use this nomogram to evaluate the status of lymph nodes in PTC patients and consider prophylactic CND for those with high scores.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Christoph Reiners, University Hospital Würzburg, Germany
This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology
Reviewed by: Jeffrey A. Knauf, Cleveland Clinic, United States; Chiara Mele, Università del Piemonte Orientale, Italy; Nicolas Schlegel, Julius Maximilian University of Würzburg, Germany
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2021.666315